Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Roivant Sciences Ltd. | 15,127,329 | reported | 13 Feb 2026 | tx 41+260,962−64,385,494 |
| APPLIED MOLECULAR EVOLUTION INC | 371,538 | reported | 09 Feb 2004 | tx 7+30,213−28,328 |
| Arbutus Biopharma Corp | 46,069 | reported | 14 Aug 2024 | tx 13+342,915−63,761 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | SALE | Roivant Sciences Ltd. | 275,000 | 26.76 USD | |
| 13 Feb 2026 | SALE | Roivant Sciences Ltd. | 150,784 | 26.49 USD | |
| 11 Feb 2026 | SALE | Roivant Sciences Ltd. | 425,000 | 26.67 USD | |
| 12 Feb 2026 | SALE | Roivant Sciences Ltd. | 150,000 | 26.72 USD | |
| 13 Feb 2026 | SALE | Roivant Sciences Ltd. | 225,000 | 26.50 USD | |
| 16 Dec 2025 | SALE | Roivant Sciences Ltd. | 275,000 | 22.93 USD | |
| 17 Dec 2025 | SALE | Roivant Sciences Ltd. | 189,538 | 23.17 USD | |
| 16 Dec 2025 | SALE | Roivant Sciences Ltd. | 642,282 | 23.08 USD | |
| 17 Dec 2025 | SALE | Roivant Sciences Ltd. | 432,718 | 23.05 USD | |
| 17 Dec 2025 | SALE | Roivant Sciences Ltd. | 155,076 | 23.02 USD | |
| 19 Nov 2025 | SALE | Roivant Sciences Ltd. | 850,000 | 20.25 USD | |
| 19 Nov 2025 | SALE | Roivant Sciences Ltd. | 150,000 | 20.20 USD | |
| 19 Nov 2025 | SALE | Roivant Sciences Ltd. | 125,000 | 20.16 USD | |
| 19 Nov 2025 | SALE | Roivant Sciences Ltd. | 175,000 | 20.24 USD | |
| 10 Sept 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 14,524 | 0.00 USD | |
| 10 Sept 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 33,726 | 0.00 USD | deriv |
| 25 Jun 2025 | OTHER | Roivant Sciences Ltd. | 6,205,368 | 0.00 USD | |
| 25 Jun 2025 | OTHER | Roivant Sciences Ltd. | 3,176,245 | 0.00 USD | |
| 25 Jun 2025 | OTHER | Roivant Sciences Ltd. | 6,837,266 | 0.00 USD | |
| 25 Jun 2025 | OTHER | Roivant Sciences Ltd. | 1,170,646 | 0.00 USD | |
| 24 Sept 2024 | SALE | Roivant Sciences Ltd. | 368,052 | 11.63 USD | |
| 25 Sept 2024 | SALE | Roivant Sciences Ltd. | 134,948 | 11.77 USD | |
| 10 Sept 2024 | GRANT_AWARD | Roivant Sciences Ltd. | 16,406 | 0.00 USD | |
| 10 Sept 2024 | GRANT_AWARD | Roivant Sciences Ltd. | 27,894 | 0.00 USD | deriv |
| 14 Aug 2024 | SALE | Arbutus Biopharma Corp | 8,846 | 3.69 USD | anomaly |